November 2014
International Journal of Pharmacy & Pharmaceutical Sciences;2014, Vol. 6 Issue 6, p270
Academic Journal
Objectives: There are many variations in prescribing patterns of Diabetes mellitus with hypertension which requires lifelong treatment as enormously increased the burden of chronic diseases and needs much care while choosing drugs. In a tertiary care centre, prescribing pattern are powerful tools to ascertain the role of drugs in society. Hence, there is a need for appropriate, safe, effective and economical study to find out the patterns of drug therapy among diabetic hypertensive patients with other complications. Methods: Retrospective, randomized and non-interventional study design was conducted from April 2012 to September 2012 at a 600 bedded multispecialty tertiary care teaching hospital in south India.The collected data are thoroughly analysed and prescriptions were checked for appropriateness. For easy sorting all data obtained were entered into Microsoft Excel 2000 and cross-checked for accuracy. The data collected were analysed to obtain averages, percentages and standard deviations. The data were grouped on the bases of age, gender, fasting blood glucose, blood pressure, co morbidities, various classes of drugs and analysed for significance. Results: Patterns of drug therapy among Diabetic hypertensive patients with other complications was observed in 117 subjects, out of which males are more affected than females in the age group of 50-60 years. The most common drug administered for Diabetes was Metformin whereas for hypertension, Telmisartan was administered. There was a positive relationship between fasting blood glucose and systolic blood pressure. Conclusion: Lacuna in the present prescribing pattern is underutilization of diuretics. Further studies from time to time are required in drug utilization pattern and standard treatment guidelines to be circulated among practicing physicians. Our study was done for a short period of time and the number of patients studied was low. Hence, similar studies covering large number of patients are needed to confirm our findings.


Related Articles

  • Managing hypertension in patients with diabetes.  // Patient Care;1/30/1994, Vol. 28 Issue 2, p15 

    Discusses the treatment of hypertension in diabetic patients. Urgency in the determination of the appropriate treatment of the hypertensive diabetic; Necessary lifestyle changes; Angiotensin converting enzyme inhibitors as drugs of choice.

  • Diabetes and intensive blood glucose control.  // American Family Physician;11/15/1993, Vol. 48 Issue 7, p1306 

    Presents a study of Wang and colleagues reported in `Lancet', May 22, 1993 issue on the effect of intensive therapy on the development of diabetic retinopathy and nephropathy. Effect of long-term intensive blood glucose control; Effect of continuous subcutaneous insulin infusion.

  • Mixing medicine & diabetes. Abramovitz, Melissa // Countdown;Summer95, Vol. 16 Issue 3, p16 

    Provides advice on the use of medicines in the treatment of other diseases related to diabetics. Evaluation of each drug in the context of treating the disease; Hard and fast rules that apply to diabetics on medication; Avoiding sympathomimetic and diuretic drugs; Nature of steroids; Risks...

  • Treatment of Dyslipidaemia with Fluvastatin in Patients with Type 2 Diabetes Mellitus: Effects on Lipids, Mental State and Fibrinolysis. Visseren, F.L.J.; Bouter, P.K.; van Loon, B.J.P.; Erkelens, W.D. // Clinical Drug Investigation;2001, Vol. 21 Issue 10, p671 

    Objective: To determine the effects of fluvastatin on lipids, mood and fibrinolysis in dyslipidaemic patients with type 2 diabetes mellitus. Design and Setting: Randomised, double-blind, placebo-controlled study in 12 outpatient clinics of general hospitals in The Netherlands evaluating the use...

  • Commentary: Economics of diabetes care must move forwards. Home, P.D. // BMJ: British Medical Journal (International Edition);12/16/95, Vol. 311 Issue 7020, p1599 

    Opinion. Focuses on the economics of diabetes care and its needs. Management of diabetes mellitus as for the most part preventive medicine; Reason for difficulty in judgments between the present and in the future in both health and economic terms; Issues related to the degree of benefit of...

  • Acute complications. Peragallo-Dittko, Virginia; Robertson, Carolyn; Hurley, Mary Lou; Begany, Timothy // RN;Aug95, Vol. 58 Issue 8, p36 

    Discusses the treatment of the acute complications of diabetes. Signs of hypoglycemia; Risk factors for hypoglycemia; Treatment of diabetic ketoacidosis; Detection of hyperglycemic hyperosmolar nonketotic syndrome.

  • Cutting the risk of complications.  // USA Today Magazine;Oct94, Vol. 123 Issue 2593, p15 

    Reports on two studies on diabetes and resulting serious complications. Intensive treatment of insulin-dependent diabetics reducing complications; Ability of angiotensin captopril to slow the advance of kidney damage.

  • Zenarestat: FK 366, FR 74366, FR 901366.  // Drugs in R&D;2002, Vol. 3 Issue 4, p235 

    Adis Comments Zenarestat [FK 366, FR 74366, FR 901366] is an orally active quinazoline derivative aldose reductase inhibitor under development with Fujisawa for the treatment of diabetic complications (neuropathy, retinopathy and cataracts). It was licensed to Parke-Davis (formerly a division of...

  • 18. Management of hypertension in patients with type 2 diabetes mellitus.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Jun2012, Vol. 17 Issue 2, pS61 

    The article discusses the treatment of hypertension in patients with type 2 diabetes mellitus. It cites the blood pressure (BP) target in diabetic patients, and provides a treatment algorithm for hypertension in these patients. Moreover, it emphasizes the importance replacing angiotensin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics